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Abstract
Hemodialysis (HD) patients have a higher risk of sud-
den death due to cardiac arrhythmias, which commonly
occur during the long interdialytic interval (LII) as a re-
sult of electrolyte fluctuations (EFs). Noninvasive moni-
toring of EFs would enable restoring normal serum elec-
trolyte levels (SELs) by performing early HD before the
onset of arrhythmias. In this study, we propose an ECG-
derived descriptor, θµ, that is noise robust and capable of
capturing EFs during HD and the LII. To investigate the
variation of θµ, ECG and blood samples of 3 patients were
acquired continuously, starting at Friday’s HD and ending
at Monday’s HD. Results show that the increase of θµ dur-
ing Friday’s HD is correlated with the decrease of SELs.
Moreover, θµ tends to decrease during the LII (no blood
samples were obtained) and further increases during Mon-
day’s HD. If results in larger databases are confirmed, θµ
might be suitable for noninvasive monitoring of EFs dur-
ing the LII.
1. Introduction
Life-threatening arrhythmias commonly occur in hemo-
dialysis (HD) patients during the long interdialytic interval
(LII), due to electrolyte fluctuations (EFs) [1]. Despite the
compelling evidence of an increased risk of sudden death
associated with abnormal serum electrolyte levels (SELs),
EFs continue to be frequently undetected [2]. Thus far,
EFs can only be detected through an invasive blood test,
which, albeit being the only clinically accepted method of
detection, is not always requested nor can be performed
at home. Noninvasive remote monitoring of EFs during
the LII (usually a weekend) would permit a prompt life-
saving reinstatement of normal SELs before the onset of
arrhythmias.
The electrical activity of the heart is inherently depen-
dent on SELs. Disturbances in the homeostatic value of
SELs can, therefore, be reflected on the electrocardiogram
(ECG) [2, 3]. While electrolyte-induced changes in the
ECG are well-known, several studies demonstrate a high
difficulty in identifying EFs solely through an ECG [4, 5].
This is mainly due to confounding diagnostics caused by
the nonspecific nature of the emblematic ECG features.
For instance, alterations in T wave and ST segment are
often associated both with hyperkalemia (increased serum
potassium ([K+]) levels) and myocardial ischemia [5].
The absence of identifiable ECG descriptors encumbers
the ability to detect EFs accurately. Thus, exploring re-
liable ECG descriptors that are influenced by SELs, partic-
ularly at non-severe levels, is crucial in the development of
new approaches to monitoring EFs at home. Recently, an
ECG descriptor capable of determining serum [K+] levels
during HD was reported in the literature [2, 3]. However,
these studies did not analyze the feasibility of using the
descriptor to monitor EFs in ambulatory settings between
HD procedures.
In this study, we propose an ECG-based descriptor ca-
pable of capturing EFs, using a wearable data acquisition
equipment. To test the proposed descriptor, we studied its
progression during HD at the time when blood was drawn
and at different points in time during the LII.
2. Methods
2.1. Data
ECG and blood samples were acquired throughout the
LII, starting at Friday’s HD session and ending at Mon-
day’s HD. Serum potassium ([K+]), magnesium ([Mg2+]),
calcium ([Ca]) and bicarbonate ([HCO−3 ]) levels were
evaluated. Three-lead ECGs were acquired using eMo-
tion Faros (Mega Electronics, Finland), whereas blood was
drawn for analysis at four-time points during each HD ses-
sion: pre-HD, 30 minutes and 1 hour after the onset of HD,
and post-HD. At each intended point in time, the ECGs
were segmented into non-overlapping 12 minute long in-
tervals, starting at 6 minutes before the specified time.
ECGs acquired during HD were labeled at the time of each
blood draw. During the LII, ECGs were analyzed at each
consecutive hour commencing one hour after finishing Fri-
day’s HD.
The patient cohort comprised of 3 patients (mean age
of 50.33±18.5 years, 1 female) and each consented par-
ticipating in two distinct sessions, i.e., during two LIIs.
The study protocol was approved by the Kaunas Regional
Biomedical Research Ethics Committee (No. BE-2-43).
2.2. ECG preprocessing
To ensure analysis of artifact-free ECGs, the segments
were filtered using a zero-phase high-pass filter with cut-
off frequency of fc=0.5Hz, followed by a zero-phase 4th
order Butterworth low-pass filter (fc=40Hz) to remove
baseline wandering and noise. PQRST complexes that did
not fulfill the signal quality index (SQI) criteria proposed
in [6] were discarded. The valid complexes were averaged
every 90-second within the segment to further smooth the
signal, ensuring a minimum of two averaged complexes
per segment. The feature extraction was applied at each
resultant PQRST complex.
2.3. T wave modeling
Abnormal electrolyte levels cause repolarization dis-
turbances in the ventricles, which are translated into al-
terations in the T wave morphology [3]. An alternative
method to quantify electrolyte-induced changes can be
through the yielded parameters of model-based parameter-
ization, a method with an increased robustness to noise that
is propitious in ambulatory ECG recordings. In our previ-
ous work, we selected a lognormal function as a model
for the T wave due to its ability to obtain an asymmetrical
shape [7]. Despite showing responsiveness to morphology
variations before and after HD, the model does not distin-
guish changes on each slope of the T wave separately. To
address this problem, we adopted a strategy similar to the
one proposed in [8] where each slope is represented by a
Gaussian function. The T wave can then be modeled using
a composite model of two distinct functions to reflect each
slope individually, and is obtained as follows:
TLG(t) = TLn(t) + TG(t), (1)
where TLn(t) and TG(t) are the lognormal and Gaus-
sian function, respectively. The right slope is defined by
TLn(t), whereas the left by TG(t), as seen in Figure 1.
Each function can be characterized by its mean (µ) and
standard deviation (σ).
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Figure 1. Illustration of the composite model fitting for a
normalized T wave. Note that the T wave is mirrored.
The final parameters extracted from the composite
model were, therefore, σR, µR, σL and µL. The first two
are derived from TLn(t) whereas the remaining ones from
TG(t). Constraints were applied to the allowed ranges of
all parameters to better control the fitting process. This en-
sures that the right slope is always fitted by TLn(t) and the
left slope by TG(t).
2.4. T wave features
When electrolyte levels decrease during HD, the T wave
tends to flatten and becomes less peaked. This variation in
peakedness is correlated with SELs and can be an indica-
tor of EFs [2,3]. A possible way to measure peakedness is
through T wave amplitude (TAmp), which, as several stud-
ies demonstrated, is unreliable in identifying EFs [5, 7].
A hypothetical method to quantify T wave peakedness is
through the angle, θ, between the right and left slopes.
Considering that each slope can be described as a line with
gradient m, θ can be calculated by:
θ = β − α
= arctan(mR)− arctan(mL),
(2)
where β and α are the angles between the temporal axis
and the right and the left slope, respectively, and mR
and mL are the gradients of the right and left slope in
mV/s, accordingly. However, when characterizing the T
wave, variations in the duration of ventricular repolariza-
tion should also be considered. Repolarization changes are
commonly reflected by a temporal displacement of each
slope, which can be translated by the yielded µR and µL
parameters of the composite model. As a result, each slope
should be represented by both its gradient (measured from
the original T wave after averaging) and temporal displace-
ment (given by the composite model) as:
SR = mR.µR
SL = mL.µL,
(3)
where mR and mL are obtained by calculating the mean
of the first derivative between T-peak and T-end point or
T-beginning point, respectively. By combining (2) and (3),
we then propose a new descriptor, θµ, to quantify T wave
peakedness:
θµ = arctan(mR.µR)− arctan(mL.µL) (4)
3. Results
With the restitution of normal SELs during HD, the T
wave returns to its more flattened idiosyncratic morphol-
ogy, which is detected by an increase of θµ, as demon-
strated in Figure 2 during Friday’s HD (θµ=0.44 rad at the
beginning of HD, whereas θµ=0.88 rad at the end). Dur-
ing Monday’s HD, the same pattern was observed between
the first blood draw at the onset of HD (θµ=0.37 rad) and
the subsequent 30 minutes (θµ=0.52 rad). Furthermore,
θµ decreased during the LII as SELs increased and the T
wave became visually more peaked.
The progression of T wave morphology over the course
of the LII is illustrated in Figure 3. Although blood was not
analyzed during the LII, we verified an increase in [K+],
[Mg2+], and [Ca] levels on the onset of Monday’s HD,
whereas [HCO−3 ] decreased, when compared to the mea-
sured levels at the end of Friday’s HD. The proposed de-
scriptor also showed a significant variation when compared
to TAmp during the LII: changes on TAmp during Saturday,
Sunday, and at the onset on Monday’s HD are almost im-
perceptible, whereas changes on θµ are more noticeable.
No arrhythmias were detected during the LII in this cohort.
4. Discussion
This study aimed to develop an approach to capture EFs
remotely before the onset of life-threatening arrhythmias
in HD patients, particularly over the course of the LII,
when the incidence of arrhythmias is higher [1]. Three
patients were enrolled in a pilot study to evaluate the pro-
posed descriptor and the feasibility of using a wearable de-
vice before proceeding to a larger cohort. Each patient dis-
played hyperkalemia, hypermagnesemia, and/or metabolic
acidosis at least once on Monday which, albeit at non-
severe levels, still increases the risk of developing abnor-
mal cardiac rhythms and supports the unmet need for non-
invasive monitoring of EFs.
The progression of θµ during HD and the LII are promis-
ing and worthy of further investigation. The proposed de-
scriptor is responsive to variations in SELs, showing an
expected increase during HD as the T wave flattened, and
a decrease over the LII as the T wave slowly became more
peaked. Moreover, θµ was measured in ECG lead I solely,
enabling the possibility to develop technologies that, not
only monitor EFs unobtrusively but also ensure long-term
wearing comfort, such as wrist-worn devices. θµ combines
the information gathered by slopes’ steepnesses, which are
associated with EFs during HD [2, 3], with parameters de-
rived from a parametrized T wave, which are advantageous
in ambulatory settings due to noise robustness. Further-
more, θµ displayed a higher sensitivity to EFs than TAmp
and might become a more identifiable ECG descriptor of
EFs.
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Figure 2. Variation of θµ (top row) compared with the synchronously acquired SELs (bottom row) of one patient. θµ
was calculated at several time points after the end of Friday’s HD. Although no blood samples were acquired during
the LII, there was a rather expected variation of SELs, with an increment of [K+]=2.6mmol/L, [Ca]=0.3mmol/L,
and [Mg2+]=0.57mmol/L, and a decline of [HCO−3 ]=6.6mmol/L, between the end of Friday’s HD and the onset of
Monday’s HD.
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Figure 3. Illustration of the T wave morphology and the progression of θµ at several time points: (a) onset of Friday’s HD,
(b) 1h from the onset, (c) end of Friday’s HD, (d) 4h after the end of HD, (e) on Saturday after 24h, (f) on Sunday after 48h
from the end of Friday’s HD, (g) the beginning of Monday’s HD.
Despite the encouraging initial results, this study
presents several limitations, one of them being the small
patient cohort. The descriptor itself also has its own limi-
tations, mainly due to the inherent difficulties of assessing
the T wave boundaries accurately in noisy conditions. In
addition, this study did not take into consideration the in-
fluence of medications, such as potassium-lowering thera-
peutics and calcium supplements, on the ECG during the
LII. Thus, we cannot correlate any discrepancies in the
measured values of θµ throughout the LII with such fac-
tors.
Future studies might consider exploring other descrip-
tors in a larger data cohort and study the influence of exter-
nal factors, such as medications and the circadian rhythm,
on the ECG during the LII. Investigating the influence of
such factors could help to reduce false alarms and develop
more accurate descriptors of EFs.
5. Conclusions
The initial results – the variation of the proposed de-
scriptor during HD and the LII - are encouraging and wor-
thy of additional investigation. θµ shows a correlation with
SELs and might be suitable to be integrated into a nonin-
vasive monitoring system of EFs during the LII between
HD procedures.
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